Differential Induction of Quinone Reductase by Phytoestrogens and Protection Against Oestrogen-induced DNA Damage

Overview

Journal Biochem J

Specialty Biochemistry

Date 2004 Oct 1

PMID 15456407

Citations 14

Authors

Nicole R Bianco

Laura J Chaplin

Monica M Montano

Affiliations

Soon will be listed here.

Abstract

Quinone reductase (QR) is a phase II detoxification enzyme that plays an important role in detoxifying quinones and may help maintain the antioxidant function of the cell. We have previously observed that QR is up-regulated by anti-oestrogens, but not oestrogen, in breast cancer cells via ERbeta (oestrogen receptor beta) transactivation. Such QR induction appears to protect breast cells against oestrogen-induced oxidative DNA damage, most likely by reducing reactive oestrogen metabolites termed catecholestrogen-quinones back to the hydroxy-catecholestrogens which may be conjugated. We now report that the phytoestrogens biochanin A, genistein and resveratrol also up-regulate QR expression in breast cancer cells. We observe that regulation can occur at the transcriptional level, preferentially through ERbeta transactivation at the electrophile response element of the QR gene promoter. By chromatin immunoprecipitation analysis, we show binding of ERalpha and ERbeta to the QR promoter, with increased ERbeta binding in the presence of resveratrol. Functional studies show that biochanin A and resveratrol, but not genistein, can significantly protect against oestrogen-induced oxidative DNA damage in breast cancer cells. Antisense technology was used to determine whether such protection was dependent on ERbeta or QR. Our results with resveratrol are consistent with our hypothesis that the protective ability of resveratrol is partially dependent on the presence of ERbeta and QR. In conclusion, we postulate that phytoestrogen-mediated induction of QR may represent an additional mechanism for breast cancer protection, although the effects may be specific for a given phytoestrogen.

Citing Articles

The Role of Resveratrol in Cancer Therapy.

Ko J, Sethi G, Um J, Shanmugam M, Arfuso F, Kumar A Int J Mol Sci. 2017; 18(12).

PMID: 29194365 PMC: 5751192. DOI: 10.3390/ijms18122589.

Botanicals and Their Bioactive Phytochemicals for Women's Health.

Dietz B, Hajirahimkhan A, Dunlap T, Bolton J Pharmacol Rev. 2016; 68(4):1026-1073.

PMID: 27677719 PMC: 5050441. DOI: 10.1124/pr.115.010843.

Chemical and biological mechanisms of phytochemical activation of Nrf2 and importance in disease prevention.

Eggler A, Savinov S Recent Adv Phytochem. 2016; 43:121-155.

PMID: 26855455 PMC: 4739799. DOI: 10.1007/978-3-319-00581-2_7.

Modulation of Estrogen Chemical Carcinogenesis by Botanical Supplements used for Postmenopausal Women's Health.

Snelten C, Dietz B, Bolton J Drug Discov Today Dis Mech. 2013; 9(1).

PMID: 24223609 PMC: 3818722. DOI: 10.1016/j.ddmec.2012.11.001.

The aryl hydrocarbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H:quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Wang L, He X, Szklarz G, Bi Y, Rojanasakul Y, Ma Q Arch Biochem Biophys. 2013; 537(1):31-8.

PMID: 23800876 PMC: 4597779. DOI: 10.1016/j.abb.2013.06.001.

References

Bhat H, Calaf G, Hei T, Loya T, Vadgama J . Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci U S A. 2003; 100(7):3913-8. PMC: 153022. DOI: 10.1073/pnas.0437929100. View

Bianco N, Perry G, Smith M, Templeton D, Montano M . Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage. Mol Endocrinol. 2003; 17(7):1344-55. DOI: 10.1210/me.2002-0382. View

Yang S, Kim J, Oh T, Kim M, Lee S, Woo S . Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray. Int J Oncol. 2003; 22(4):741-50. View

Seike N, Wanibuchi H, Morimura K, Wei M, Nishikawa T, Hirata K . Enhancement of lung carcinogenesis by nonylphenol and genistein in a F344 rat multiorgan carcinogenesis model. Cancer Lett. 2003; 192(1):25-36. DOI: 10.1016/s0304-3835(02)00684-5. View

Magee P, Rowland I . Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer. Br J Nutr. 2004; 91(4):513-31. DOI: 10.1079/BJN20031075. View

Begleiter A, Fourie J . Induction of NQO1 in cancer cells. Methods Enzymol. 2004; 382:320-51. DOI: 10.1016/S0076-6879(04)82018-4. View

Montano M, Ekena K, Krueger K, Keller A, Katzenellenbogen B . Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens. Mol Endocrinol. 1996; 10(3):230-42. DOI: 10.1210/mend.10.3.8833652. View

Montano M, Katzenellenbogen B . The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc Natl Acad Sci U S A. 1997; 94(6):2581-6. PMC: 20131. DOI: 10.1073/pnas.94.6.2581. View

Nioi P, McMahon M, Itoh K, Yamamoto M, Hayes J . Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem J. 2003; 374(Pt 2):337-48. PMC: 1223621. DOI: 10.1042/BJ20030754. View

10.

Barkhem T, Nilsson S, Gustafsson J . Molecular mechanisms, physiological consequences and pharmacological implications of estrogen receptor action. Am J Pharmacogenomics. 2004; 4(1):19-28. DOI: 10.2165/00129785-200404010-00003. View

11.

Murata M, Midorikawa K, Koh M, Umezawa K, Kawanishi S . Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs. Biochemistry. 2004; 43(9):2569-77. DOI: 10.1021/bi035613d. View

12.

Talalay P, Dinkova-Kostova A . Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates. Methods Enzymol. 2004; 382:355-64. DOI: 10.1016/S0076-6879(04)82019-6. View

13.

Nguyen T, Yang C, Pickett C . The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med. 2004; 37(4):433-41. DOI: 10.1016/j.freeradbiomed.2004.04.033. View

14.

Roy D, Liehr J . Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. Increased superoxide formation by redox cycling of estrogen. J Biol Chem. 1988; 263(8):3646-51. View

15.

Paulus W, Baur I, Boyce F, Breakefield X, Reeves S . Self-contained, tetracycline-regulated retroviral vector system for gene delivery to mammalian cells. J Virol. 1996; 70(1):62-7. PMC: 189788. DOI: 10.1128/JVI.70.1.62-67.1996. View

16.

Wei H, Cai Q, Rahn R . Inhibition of UV light- and Fenton reaction-induced oxidative DNA damage by the soybean isoflavone genistein. Carcinogenesis. 1996; 17(1):73-7. DOI: 10.1093/carcin/17.1.73. View

17.

PETERSON T, Coward L, Kirk M, Falany C, Barnes S . The role of metabolism in mammary epithelial cell growth inhibition by the isoflavones genistein and biochanin A. Carcinogenesis. 1996; 17(9):1861-9. DOI: 10.1093/carcin/17.9.1861. View

18.

Shen L, Pisha E, Huang Z, Pezzuto J, Krol E, Alam Z . Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity. Carcinogenesis. 1997; 18(5):1093-101. DOI: 10.1093/carcin/18.5.1093. View

19.

Hayashi S, Makino Y, Eguchi H, Yodoi J, Tanaka H . Functional modulation of estrogen receptor by redox state with reference to thioredoxin as a mediator. Nucleic Acids Res. 1997; 25(20):4035-40. PMC: 146993. DOI: 10.1093/nar/25.20.4035. View

20.

Wang W, Liu L, Higuchi C, Chen H . Induction of NADPH:quinone reductase by dietary phytoestrogens in colonic Colo205 cells. Biochem Pharmacol. 1998; 56(2):189-95. DOI: 10.1016/s0006-2952(98)00141-5. View